Calendar events

26 MAY 2021 – BACK TO THE FUTURE: HIV VACCINE LEARNINGS

An event to engage scientists, clinicians, industry, funders, and community representatives on how best to learn from past efficacy trials to inform future vaccine development efforts.

Enterprise – Communication Training Workshop 2021 (announcement)

The Global HIV Vaccine Enterprise at the IAS – International AIDS Society, and IAVI, are pleased to announce a Communication Training Workshop for early-mid career African researchers working in HIV vaccine research and development.

HIV R4P Virtual News

HIV vaccine highlights and spotlights – To help attendees manage their time and navigate a busy programme, the Enterprise has developed an HIV vaccine R&D roadmap which covers active immunization and  passive immunization with broadly neutralizing antibodies (bNAbs), especially VRC01.

Making mAb Accessible webinar

The Global HIV Vaccine Enterprise at the International AIDS Society and IAVI are pleased to invite you to join a webinar to discuss challenges and opportunities on the Access to future monoclonal antibodies for HIV prevention:

“Making monoclonal antibodies broadly accessible to communities most at risk of HIV/AIDS – What would it take?’’

VIRTUAL WORKSHOP SERIES

NOW VIRTUAL ! This scientific and technical workshop aims to continue from the first HIV Prevention Efficacy Trial Designs of the Future symposium, held in November 2018 in Seattle by the Fred Hutch and the NIAID. Participants will reflect on more recent advances and challenges within the HIV prevention field and on the rationale and lessons learned for current HIV prevention designs.

Enterprise workshop trial design R4P

This scientific and technical workshop aims to continue from the first HIV Prevention Efficacy Trial Designs of the Future symposium, held in November 2018 in Seattle by the Fred Hutch and the NIAID. Participants will reflect on more recent advances and challenges within the HIV prevention field and on the rationale and lessons learned for current HIV prevention designs.

Enterprise Workshop – Kigali 2019

Are you an African researcher or a clinician working on HIV vaccine research and development (R&D)? Are you interested in sharing your experience and the challenges you face in your daily work? Are you keen to develop practical solutions to support African researchers towards the development of a safe and effective HIV vaccine?

The Global HIV Vaccine Enterprise invites you to apply to attend an interactive half-day workshop in Kigali.

HIV Vaccine R&D at the IAS Science Conference 2019

The IAS Conference on HIV Science is the world’s most influential meeting on HIV research and its applications. This biennial conference presents the critical advances in basic, clinical and operational research that moves science into policy and practice. Through its open and inclusive programme development, the meeting sets the gold standard of HIV research featuring highly diverse and cutting-edge studies.

HIV Vaccine research and development will be very much featured before and during the conference.